Literature DB >> 25988826

The opioid receptors as targets for drug abuse medication.

Florence Noble1,2,3, Magalie Lenoir1,2,3, Nicolas Marie1,2,3.   

Abstract

The endogenous opioid system is largely expressed in the brain, and both endogenous opioid peptides and receptors are present in areas associated with reward and motivation. It is well known that this endogenous system plays a key role in many aspects of addictive behaviours. The present review summarizes the modifications of the opioid system induced by chronic treatment with drugs of abuse reported in preclinical and clinical studies, as well as the action of opioid antagonists and agonists on the reinforcing effects of drugs of abuse, with therapeutic perspectives. We have focused on the effects of chronic psychostimulants, alcohol and nicotine exposure. Taken together, the changes in both opioid peptides and opioid receptors in different brain structures following acute or chronic exposure to these drugs of abuse clearly identify the opioid system as a potential target for the development of effective pharmacotherapy for the treatment of addiction and the prevention of relapse.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25988826      PMCID: PMC4543606          DOI: 10.1111/bph.13190

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  244 in total

1.  LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.

Authors:  Linda M Rorick-Kehn; Jeffrey M Witkin; Michael A Statnick; Elizabeth L Eberle; Jamie H McKinzie; Steven D Kahl; Beth M Forster; Conrad J Wong; Xia Li; Robert S Crile; David B Shaw; Allison E Sahr; Benjamin L Adams; Steven J Quimby; Nuria Diaz; Alma Jimenez; Concepcion Pedregal; Charles H Mitch; Kelly L Knopp; Wesley H Anderson; Jeffrey W Cramer; David L McKinzie
Journal:  Neuropharmacology       Date:  2013-09-23       Impact factor: 5.250

2.  β-endorphin via the delta opioid receptor is a major factor in the incubation of cocaine craving.

Authors:  Yahav Dikshtein; Royi Barnea; Noam Kronfeld; Elad Lax; Ilana Roth-Deri; Alexander Friedman; Iris Gispan; Einat Elharrar; Sarit Levy; Moshe Ben-Tzion; Gal Yadid
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

3.  Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

Authors:  James C Garbutt; Henry R Kranzler; Stephanie S O'Malley; David R Gastfriend; Helen M Pettinati; Bernard L Silverman; John W Loewy; Elliot W Ehrich
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

4.  A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

Authors:  Antoni Gual; Yuan He; Lars Torup; Wim van den Brink; Karl Mann
Journal:  Eur Neuropsychopharmacol       Date:  2013-04-03       Impact factor: 4.600

5.  A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.

Authors:  Conrad J Wong; Jennifer Witcher; Craig Mallinckrodt; Robert A Dean; Raymond F Anton; Yunfei Chen; Bonnie A Fijal; Haojun Ouyang; Sweta Dharia; Scott S Sundseth; Kory J Schuh; Bruce J Kinon
Journal:  Alcohol Clin Exp Res       Date:  2013-09-06       Impact factor: 3.455

6.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.

Authors:  Fernando Berrendero; Victoria Mendizábal; Patricia Robledo; Lola Galeote; Andras Bilkei-Gorzo; Andreas Zimmer; Rafael Maldonado
Journal:  J Neurosci       Date:  2005-02-02       Impact factor: 6.167

Review 8.  Neuroscience of behavioral and pharmacological treatments for addictions.

Authors:  Marc N Potenza; Mehmet Sofuoglu; Kathleen M Carroll; Bruce J Rounsaville
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

Review 9.  15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse.

Authors:  Pauline Charbogne; Brigitte L Kieffer; Katia Befort
Journal:  Neuropharmacology       Date:  2013-09-10       Impact factor: 5.250

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  5 in total

Review 1.  Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response.

Authors:  Burcu Balkan; Sakire Pogun
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

2.  Oxycodone self-administration activates the mitogen-activated protein kinase/ mitogen- and stress-activated protein kinase (MAPK-MSK) signaling pathway in the rat dorsal striatum.

Authors:  Christopher A Blackwood; Michael T McCoy; Bruce Ladenheim; Jean Lud Cadet
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.996

Review 3.  Epigenetic Modulation of Opioid Receptors by Drugs of Abuse.

Authors:  Ke Zhang Reid; Brendan Matthew Lemezis; Tien-Chi Hou; Rong Chen
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

4.  Nicotine increases alcohol self-administration in male rats via a μ-opioid mechanism within the mesolimbic pathway.

Authors:  Esi Domi; Li Xu; Marvin Pätz; Anton Nordeman; Gaëlle Augier; Lovisa Holm; Sanne Toivainen; Eric Augier; Anita C Hansson; Markus Heilig
Journal:  Br J Pharmacol       Date:  2020-08-14       Impact factor: 8.739

5.  Tramadol Treatment Induces Change in Phospho-Cyclic Adenosine Monophosphate Response Element-Binding Protein and Delta and Mu Opioid Receptors within Hippocampus and Amygdala Areas of Rat Brain.

Authors:  Hamid Ahmadian-Moghadam; Mitra Sadat Sadat-Shirazi; Somaiyeh Azmoun; Reza Vafadoost; Solmaz Khalifeh; Mohammad Reza Zarrindast
Journal:  Addict Health       Date:  2021-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.